eScholarship
metadata only
Mesenchymal stem/stromal cell therapy improves immune recovery in a feline model of severe coronavirus infection
Severe coronavirus infections, including SARS-CoV-2, are marked by systemic inflammation, T-cell exhaustion, lymphopenia, and chronic immune dysfunction, with limited therapeutic options for recovery. Feline infectious peritonitis (FIP), a naturally occurring feline coronavirus infection, mirrors th
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mesenchymal Stem Cells and Myocardial Ischemia#1164746
- Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19#871590
- Prevention and Treatment of Patient Before, During, and After Covid-19 Infection#847990
- Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design#780556
- Cardiac stem cell therapy following myocardial infarction: a systematic review and meta-analysis of randomized controlled trials#190981
Record · ID 1079101
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive